Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A.

J Clin Invest. 2008 Feb;118(2):534-44. doi: 10.1172/JCI33194.

2.

Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis.

Lee MJ, Lee JK, Choi JW, Lee CS, Sim JH, Cho CH, Lee KH, Cho IH, Chung MH, Kim HR, Ye SK.

PLoS One. 2012;7(9):e38801. doi: 10.1371/journal.pone.0038801.

3.

Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.

Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA.

PLoS Med. 2008 Mar 4;5(3):e54. doi: 10.1371/journal.pmed.0050054.

4.

Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.

Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH.

World J Gastroenterol. 2013 May 7;19(17):2638-49. doi: 10.3748/wjg.v19.i17.2638.

5.

Interleukin-19 protects mice from innate-mediated colonic inflammation.

Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, Nakajima H, Karow M, Takeuchi T.

Inflamm Bowel Dis. 2010 Jun;16(6):1017-28. doi: 10.1002/ibd.21151.

PMID:
19834971
6.

IL-33 promotes GATA-3 polarization of gut-derived T cells in experimental and ulcerative colitis.

Seidelin JB, Coskun M, Kvist PH, Holm TL, Holgersen K, Nielsen OH.

J Gastroenterol. 2015 Feb;50(2):180-90. doi: 10.1007/s00535-014-0982-7.

PMID:
25112700
7.

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice.

Sedhom MA, Pichery M, Murdoch JR, Foligné B, Ortega N, Normand S, Mertz K, Sanmugalingam D, Brault L, Grandjean T, Lefrancais E, Fallon PG, Quesniaux V, Peyrin-Biroulet L, Cathomas G, Junt T, Chamaillard M, Girard JP, Ryffel B.

Gut. 2013 Dec;62(12):1714-23. doi: 10.1136/gutjnl-2011-301785.

8.

Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.

Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, Touil-Boukoffa C.

Immunopharmacol Immunotoxicol. 2013 Jun;35(3):403-9. doi: 10.3109/08923973.2013.790413.

PMID:
23638770
9.

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, Ouyang W, Neurath MF, Becker C.

J Exp Med. 2009 Jul 6;206(7):1465-72. doi: 10.1084/jem.20082683.

10.

STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.

Rosen MJ, Chaturvedi R, Washington MK, Kuhnhein LA, Moore PD, Coggeshall SS, McDonough EM, Weitkamp JH, Singh AB, Coburn LA, Williams CS, Yan F, Van Kaer L, Peebles RS Jr, Wilson KT.

J Immunol. 2013 Feb 15;190(4):1849-58. doi: 10.4049/jimmunol.1201373.

11.

Chronic colitis induces expression of β-defensins in murine intestinal epithelial cells.

Rahman A, Fahlgren A, Sundstedt C, Hammarström S, Danielsson A, Hammarström ML.

Clin Exp Immunol. 2011 Jan;163(1):123-30. doi: 10.1111/j.1365-2249.2010.04282.x.

13.

Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.

Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N, Kido M, Inoue S, Mikami S, Asada M, Kiriya K, Kitamura H, Ohashi S, Fukui T, Kawasaki K, Matsuura M, Ishii Y, Okazaki K, Yodoi J, Chiba T.

Gastroenterology. 2006 Oct;131(4):1110-21.

PMID:
17030181
14.

A role for interleukin-33 in T(H)2-polarized intestinal inflammation?

Seidelin JB, Rogler G, Nielsen OH.

Mucosal Immunol. 2011 Sep;4(5):496-502. doi: 10.1038/mi.2011.22. Review.

PMID:
21613987
15.

MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

Koukos G, Polytarchou C, Kaplan JL, Morley-Fletcher A, Gras-Miralles B, Kokkotou E, Baril-Dore M, Pothoulakis C, Winter HS, Iliopoulos D.

Gastroenterology. 2013 Oct;145(4):842-52.e2. doi: 10.1053/j.gastro.2013.07.001.

16.

Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6/STAT3 signaling pathway.

Yang X, Zhang F, Wang Y, Cai M, Wang Q, Guo Q, Li Z, Hu R.

Inflamm Bowel Dis. 2013 Aug;19(9):1990-2000. doi: 10.1097/MIB.0b013e318293c5e0.

PMID:
23823704
17.

Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells.

Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Fränk M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R.

Am J Pathol. 2013 Mar;182(3):1005-20. doi: 10.1016/j.ajpath.2012.11.026.

PMID:
23438478
18.

γδ T-cell-deficient mice show alterations in mucin expression, glycosylation, and goblet cells but maintain an intact mucus layer.

Kober OI, Ahl D, Pin C, Holm L, Carding SR, Juge N.

Am J Physiol Gastrointest Liver Physiol. 2014 Apr 1;306(7):G582-93. doi: 10.1152/ajpgi.00218.2013.

19.

Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization.

Lin Y, Yang X, Yue W, Xu X, Li B, Zou L, He R.

Cell Mol Immunol. 2014 Jul;11(4):355-66. doi: 10.1038/cmi.2014.15.

20.

Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.

Tang R, Yang G, Zhang S, Wu C, Chen M.

Inflamm Bowel Dis. 2014 Nov;20(11):1950-61. doi: 10.1097/MIB.0000000000000192.

PMID:
25208103
Items per page

Supplemental Content

Support Center